Business Description
Anterogen Co Ltd
ISIN : KR7065660003
Compare
Compare
Traded in other countries / regions
065660.Korea IPO Date
2016-02-15Description
Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.16 | |||||
| Equity-to-Asset | 0.97 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -9.85 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 22.83 | |||||
| Beneish M-Score | -2.34 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.9 | |||||
| 3-Year EBITDA Growth Rate | 48.5 | |||||
| 3-Year EPS without NRI Growth Rate | 4.2 | |||||
| 3-Year FCF Growth Rate | 40.6 | |||||
| 3-Year Book Growth Rate | 14.3 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 72.63 | |||||
| 9-Day RSI | 62.2 | |||||
| 14-Day RSI | 56.6 | |||||
| 6-1 Month Momentum % | -3.57 | |||||
| 12-1 Month Momentum % | 3.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 45.24 | |||||
| Quick Ratio | 44.24 | |||||
| Cash Ratio | 40 | |||||
| Days Inventory | 165.84 | |||||
| Days Sales Outstanding | 132.24 | |||||
| Days Payable | 67.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.3 | |||||
| Shareholder Yield % | 1.64 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.01 | |||||
| Operating Margin % | -58.12 | |||||
| Net Margin % | -34.75 | |||||
| FCF Margin % | -1.7 | |||||
| ROE % | -1.89 | |||||
| ROA % | -1.7 | |||||
| ROIC % | -4.22 | |||||
| ROC (Joel Greenblatt) % | -6.68 | |||||
| ROCE % | -1.35 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 21.92 | |||||
| PB Ratio | 1.27 | |||||
| Price-to-Tangible-Book | 1.34 | |||||
| EV-to-EBIT | -60.15 | |||||
| EV-to-EBITDA | -106.52 | |||||
| EV-to-Revenue | 15.83 | |||||
| EV-to-FCF | -843.7 | |||||
| Price-to-Projected-FCF | 5.01 | |||||
| Price-to-Net-Current-Asset-Value | 3.46 | |||||
| Price-to-Net-Cash | 3.95 | |||||
| Earnings Yield (Greenblatt) % | -1.67 | |||||
| FCF Yield % | -0.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Anterogen Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 6,658.714 | ||
| EPS (TTM) (â‚©) | -238 | ||
| Beta | 1.27 | ||
| Volatility % | 37.05 | ||
| 14-Day RSI | 56.6 | ||
| 14-Day ATR (â‚©) | 569.837762 | ||
| 20-Day SMA (â‚©) | 14341 | ||
| 12-1 Month Momentum % | 3.24 | ||
| 52-Week Range (â‚©) | 12300 - 19150 | ||
| Shares Outstanding (Mil) | 9.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Anterogen Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Anterogen Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Anterogen Co Ltd Frequently Asked Questions
What is Anterogen Co Ltd(XKRX:065660)'s stock price today?
The current price of XKRX:065660 is â‚©15000.00. The 52 week high of XKRX:065660 is â‚©19150.00 and 52 week low is â‚©12300.00.
When is next earnings date of Anterogen Co Ltd(XKRX:065660)?
The next earnings date of Anterogen Co Ltd(XKRX:065660) is .
Does Anterogen Co Ltd(XKRX:065660) pay dividends? If so, how much?
Anterogen Co Ltd(XKRX:065660) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers